With no margin for rebellion, Senate Democrats pushed toward a crucial weekend test vote on their sweeping health care bill Friday, and wavering moderates appeared to be falling in line on President Barack Obama's signature issue.

Congressional budget crunchers said  the Democrats' latest health care plan would hold down federal red ink for at least 20 years, an assessment that gave supporters hope as the Senate moved gingerly toward  debate.

The US Senate released a long-awaited healthcare reform plan on that budget analysts said would extend coverage to tens of millions of the uninsured and reduce the deficit over 10 years.

Doctors completed the sixth successful procedure of a revolutionary brain cancer treatment. It forgoes traditional methods and administers Genentech's  chemo drug, Avastan directly into the tumor.

A U.S. clinical study suggests that just half a dose of the Novartis AG H1N1 vaccine may be enough to generate a protective immune response, the Swiss drugmaker said on Tuesday.

The most important new antidiscrimination law in two decades — the Genetic Information Nondiscrimination Act — will take effect in the nation’s workplaces next weekend, prohibiting employers from requesting genetic testing or considering someone’s genetic background in hiring, firing or promotions. The New York Times explaines the ramifications.

Even as drug makers promise to support Washington’s health care overhaul by shaving $8 billion a year off the nation’s drug costs after the legislation takes effect, the industry has been raising its prices at the fastest rate in years, reports the New York Times.

GlaxoSmithKline has won U.S. marketing approval to sell an unadjuvanted H1N1 swine vaccine, allowing it to ship relatively modest amounts of scarce vaccine to the United States next month.

As health care legislation moves to the Senate, there is a growing criticism that the measure doesn't fulfill President Obama’s promise to slow runaway health care costs, the New York Times reports.

A government health insurance plan included in the House bill is unacceptable to a few Democratic moderates who hold the balance of power in the Senate.

The healthcare reform that the House of Representatives approved late Saturday is bad for the US and will actually damage the health care system, Steve Forbes, CEO at Forbes, told CNBC Monday.

After a landmark win in the U.S. House of Representatives, President Barack Obama's push for healthcare reform faces a difficult path in the Senate.

Democratic leaders in the U.S. House scrambled Friday to allay lingering concerns about a broad health care overhaul and raised the possibility a vote planned for Saturday could slip into next week.

When makers of heart defibrillators wanted Medicare to vastly expand the types of patients eligible to receive the devices, which can cost upward of $25,000, agency officials were skeptical. It was not clear how many of those patients would actually need a defibrillator, a device that can deliver a life-saving shock to restore a faltering heart to normal rhythm.

Urged on by President Barack Obama, Democratic leaders in the U.S. House hustled Thursday to round up support for a sweeping health care overhaul headed to a close floor vote Saturday.